{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:13:28Z","timestamp":1784632408182,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thyroid Res"],"DOI":"10.1186\/s13044-026-00309-3","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:07:05Z","timestamp":1783566425000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TSH receptor autoantibodies \u2013 a personal experience"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9789-2484","authenticated-orcid":false,"given":"Bernard","family":"Rees Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"309_CR1","first-page":"11","volume":"34","author":"DD Adams","year":"1956","unstructured":"Adams DD, Purves HD. Abnormal responses in the assay of thyrotropin. Proc Univ Otago M Sch. 1956;34:11\u201312.","journal-title":"Proc Univ Otago M Sch"},{"issue":"6947","key":"309_CR2","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S0140-6736(56)92249-8","volume":"268","author":"IM Roitt","year":"1956","unstructured":"Roitt IM, Doniach D, Campbell PN, Hudson RV. Auto-antibodies in Hashimoto\u2019s disease (lymphadenoid goitre). Lancet. 1956;268(6947):820\u201321. https:\/\/doi.org\/10.1016\/S0140-6736(56)92249-8.","journal-title":"Lancet"},{"issue":"5441","key":"309_CR3","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1136\/bmj.1.5441.1015","volume":"1","author":"DD Adams","year":"1965","unstructured":"Adams DD. Pathogenesis of the hyperthyroidism of Graves\u2019s disease. Br Med J. 1965;1(5441):1015\u201319. https:\/\/doi.org\/10.1136\/bmj.1.5441.1015.","journal-title":"Br Med J"},{"issue":"4636","key":"309_CR4","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/182670a0","volume":"182","author":"RR Porter","year":"1958","unstructured":"Porter RR. Separation and isolation of fractions of rabbit gamma-globulin containing the antibody and antigenic combining sites. Nature. 1958;182(4636):670\u201371. https:\/\/doi.org\/10.1038\/182670a0.","journal-title":"Nature"},{"issue":"2","key":"309_CR5","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1042\/bj0880220","volume":"88","author":"JB Fleischman","year":"1963","unstructured":"Fleischman JB, Porter RR, Press EM. The arrangement of the peptide chains in gamma-globulin. Biochem J. 1963;88(2):220\u201328. https:\/\/doi.org\/10.1042\/bj0880220.","journal-title":"Biochem J"},{"issue":"6","key":"309_CR6","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/cpt196676788","volume":"7","author":"KJ Dorrington","year":"1966","unstructured":"Dorrington KJ, Munro DS. The long-acting thyroid stimulator. Clin Pharmacol Ther. 1966;7(6):788\u2013806. https:\/\/doi.org\/10.1002\/cpt196676788.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"309_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0304-4165(69)90366-3","volume":"192","author":"BR Smith","year":"1969","unstructured":"Smith BR, Dorrington KJ, Munro DS. The thyroid-stimulating properties of long-acting thyroid stimulator \u03b3G-globulin subunits. Biochim Biophys Acta. 1969;192(2):277\u201385. https:\/\/doi.org\/10.1016\/0304-4165(69)90366-3.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"309_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1677\/joe.0.0460045","volume":"46","author":"BR Smith","year":"1970","unstructured":"Smith BR. The interaction of the long-acting thyroid stimulator (LATS) with thyroid tissue in vitro. J Endocrinol. 1970;46(1):45\u201354. https:\/\/doi.org\/10.1677\/joe.0.0460045.","journal-title":"J Endocrinol"},{"issue":"3","key":"309_CR9","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/0005-2795(71)90281-9","volume":"229","author":"BR Smith","year":"1971","unstructured":"Smith BR. Characterisation of long-acting thyroid stimulator \u03b3G binding protein. Biochim Biophys Acta. 1971;229(3):649\u201362. https:\/\/doi.org\/10.1016\/0005-2795(71)90281-9.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"309_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0304-4165(70)90247-3","volume":"208","author":"BR Smith","year":"1970","unstructured":"Smith BR, Munro DS. The nature of the interaction between thyroid stimulating \u03b3G-globulin (long-acting thyroid stimulatory) and thyroid tissue. Biochim Biophys Acta. 1970;208(2):285\u201393. https:\/\/doi.org\/10.1016\/0304-4165(70)90247-3.","journal-title":"Biochim Biophys Acta"},{"issue":"7878","key":"309_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0140-6736(74)91815-7","volume":"304","author":"BR Smith","year":"1974","unstructured":"Smith BR, Hall R. Thyroid-stimulating immunoglobulins in Graves\u2019 disease. Lancet. 1974;304(7878):427\u201330. https:\/\/doi.org\/10.1016\/S0140-6736(74)91815-7.","journal-title":"Lancet"},{"issue":"1","key":"309_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1210\/edrv-9-1-106","volume":"9","author":"B Rees Smith","year":"1988","unstructured":"Rees Smith B, McLaughlan SM, Furmaniak J. Autoantibodies to the thyrotropin receptor. Endocr Rev. 1988;9(1):106\u201321. https:\/\/doi.org\/10.1210\/edrv-9-1-106.","journal-title":"Endocr Rev"},{"issue":"5","key":"309_CR13","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1210\/jcem-46-5-734","volume":"46","author":"K Endo","year":"1978","unstructured":"Endo K, Kasagi K, Konishi J, Ikekubo K, Okuno T, Takeda Y, et al. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves\u2019 disease and Hashimoto\u2019s thyroiditis. J Clin Endocrinol Metab. 1978;46(5):734\u201339. https:\/\/doi.org\/10.1210\/jcem-46-5-734.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"309_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1365-2265.1977.tb03316.x","volume":"6","author":"CS Teng","year":"1977","unstructured":"Teng CS, Smith BR, Clayton B, Evered DC, Clark F, Hall R. Thyroid-stimulating immunoglobulins in ophthalmic Graves\u2019 disease. Clin Endocrinol (Oxf). 1977;6(3):207\u201311. https:\/\/doi.org\/10.1111\/j.1365-2265.1977.tb03316.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"309_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1365-2265.1982.tb01607.x","volume":"17","author":"G Shewring","year":"1982","unstructured":"Shewring G, Smith BR. An improved radioreceptor assay for TSH receptor antibodies. Clin Endocrinol (Oxf). 1982;17(4):409\u201317. https:\/\/doi.org\/10.1111\/j.1365-2265.1982.tb01607.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"309_CR16","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1365-2265.1984.tb00102.x","volume":"20","author":"K Southgate","year":"1984","unstructured":"Southgate K, Creagh F, Teece M, Kingswood C, Rees Smith B. A receptor assay for the measurement of TSH receptor antibodies in unextracted serum. Clin Endocrinol (Oxf). 1984;20(5):539\u201343. https:\/\/doi.org\/10.1111\/j.1365-2265.1984.tb00102.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"309_CR17","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1210\/mend-4-8-1264","volume":"4","author":"AL Frazier","year":"1990","unstructured":"Frazier AL, Robbins LS, Stork PJ, Sprengel R, Segaloff DL, Cone RD. Isolation of TSH and LH\/CG receptor cDnas from human thyroid: regulation by tissue specific splicing. Mol Endocrinol. 1990;4(8):1264\u201376. https:\/\/doi.org\/10.1210\/mend-4-8-1264.","journal-title":"Mol Endocrinol"},{"issue":"4937","key":"309_CR18","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1126\/science.2556796","volume":"246","author":"M Parmentier","year":"1989","unstructured":"Parmentier M, Libert F, Maenhaut C, Lefort A, G\u00e9rard C, Perret J, et al. Molecular cloning of the thyrotropin receptor. Science. 1989;246(4937):1620\u201322. https:\/\/doi.org\/10.1126\/science.2556796.","journal-title":"Science"},{"issue":"3","key":"309_CR19","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/0006-291X(89)92727-7","volume":"165","author":"Y Nagayama","year":"1989","unstructured":"Nagayama Y, Kaufman KD, Seto P, Rapoport B. Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem Biophys Res Commun. 1989;165(3):1184\u201390. https:\/\/doi.org\/10.1016\/0006-291X(89)92727-7.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"309_CR20","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/0006-291X(90)91958-U","volume":"166","author":"M Misrahi","year":"1990","unstructured":"Misrahi M, Loosfelt H, Atger M, Sar S, Guiochon-Mantel A, Milgrom E. Cloning, sequencing and expression of human TSH receptor. Biochem Biophys Res Commun. 1990;166(1):394\u2013403. https:\/\/doi.org\/10.1016\/0006-291X(90)91958-U.","journal-title":"Biochem Biophys Res Commun"},{"key":"309_CR21","unstructured":"Sanders J, Furmaniak J, Rees Smith B. Antibody for the thyrotropin receptor and uses thereof. EP 1565493 B1 (priority 29.11.2002 GB 0227964)."},{"issue":"9378","key":"309_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S0140-6736(03)13866-4","volume":"362","author":"J Sanders","year":"2003","unstructured":"Sanders J, Evans M, Premawardhana LD, Depraetere H, Jeffreys J, Richards T, et al. Human monoclonal thyroid stimulating autoantibody. Lancet. 2003;362(9378):126\u201328. https:\/\/doi.org\/10.1016\/S0140-6736(03)13866-4.","journal-title":"Lancet"},{"key":"309_CR23","unstructured":"Gassner D, Golla R, Stock W, Yoshimura HJ, Sanders J, Rees Smith B. Development of a new automated assay for thyrotropin receptor autoantibodies on the Elecsys system. Clin Chem. 2007;53 Suppl:A145."},{"issue":"5","key":"309_CR24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1089\/thy.2007.0034","volume":"17","author":"J Sanders","year":"2007","unstructured":"Sanders J, Chirgadze D, Sanders P, Baker S, Sullivan A, Bhardwaja A, et al. Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. Thyroid. 2007;17(5):395\u2013410. https:\/\/doi.org\/10.1089\/thy.2007.0034.","journal-title":"Thyroid"},{"issue":"10","key":"309_CR25","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/1439-7633(20021004)3:10<1023::AID-CBIC1023>3.0.CO;2-9","volume":"3","author":"NC van Straten","year":"2002","unstructured":"van Straten NC, Schoonus-Gerritsma GG, van Someren RG, Draaijer J, Adang AE, Timmers CM, et al. The first orally active low molecular weight agonists for the LH receptor: Thienopyr(im)idines with therapeutic potential for ovulation induction. Chembiochem. 2002;3(10):1023\u201326. https:\/\/doi.org\/10.1002\/1439-7633(20021004)3:10%3C1023::AID-CBIC1023%3E3.0.CO;2-9.","journal-title":"Chembiochem"},{"issue":"7","key":"309_CR26","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1111\/j.1476-5381.2011.01709.x","volume":"165","author":"CJ van Koppen","year":"2012","unstructured":"van Koppen CJ, de Gooyer ME, Karstens WJ, Plate R, Conti PG, van Achterberg TA, et al. Mechanism of action of a nanomolar potent, allosteric antagonist of the thyroid-stimulating hormone receptor. Br J Pharmacol. 2012;165(7):2314\u201324. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01709.x.","journal-title":"Br J Pharmacol"},{"key":"309_CR27","doi-asserted-by":"publisher","unstructured":"van Zeijl CJJ, van Koppen CJ, Surovtseva OV, de Gooyer ME, Plate R, Conti P, et al. Complete inhibition of rhTSH-, Graves\u2019 disease IgG-, and M22 induced cAMP production in differentiated fibroblasts by a low molecular-weight TSHR antagonist. J Clin Endocrinol Metab. 2012;97(5):E781\u201385. https:\/\/doi.org\/10.1210\/jc.2011-2931.","DOI":"10.1210\/jc.2011-2931"},{"issue":"11","key":"309_CR28","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1507\/endocrj.EJ25-0127","volume":"72","author":"B Rees Smith","year":"2025","unstructured":"Rees Smith B. Autoantibodies to the TSH receptor - from discovery to understanding the mechanisms of action and to new therapeutics. Endocr J. 2025;72(11):1163\u201374. https:\/\/doi.org\/10.1507\/endocrj.EJ25-0127.","journal-title":"Endocr J"},{"key":"309_CR29","doi-asserted-by":"publisher","unstructured":"Rees Smith B, N\u00fa\u00f1ez Miguel R, Sanders J. The thyrotropin receptor structure and interactions with autoantibodies. Eur Thyroid J. 2025;14(6):14 e250261. https:\/\/doi.org\/10.1530\/ETJ-25-0261.","DOI":"10.1530\/ETJ-25-0261"},{"key":"309_CR30","unstructured":"Rees Smith B, Furmaniak J, Sanders J. Epitope regions of a thyrotropin (TSH) receptor, uses thereof and antibodies thereto. EP 1456234 B1 (priority 23.08.2001 GB 0120649)."},{"issue":"12","key":"309_CR31","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1089\/105072502321085135","volume":"12","author":"J Sanders","year":"2002","unstructured":"Sanders J, Jeffreys J, Depraetere H, Richards T, Evans M, Kiddie A, et al. Thyroid-stimulating monoclonal antibodies. Thyroid. 2002;12(12):1043\u201350. https:\/\/doi.org\/10.1089\/105072502321085135.","journal-title":"Thyroid"},{"issue":"11","key":"309_CR32","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1172\/JCI0216991","volume":"110","author":"T Ando","year":"2002","unstructured":"Ando T, Latif R, Pritsker A, Moran T, Nagayama Y, Davies TF. A monoclonal thyroid-stimulating antibody. 2002. J Clin Invest. 2002;110(11):1667\u201374. https:\/\/doi.org\/10.1172\/JCI0216991.","journal-title":"J Clin Invest"},{"issue":"12","key":"309_CR33","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1089\/105072502321085126","volume":"12","author":"S Costagliola","year":"2002","unstructured":"Costagliola S, Vassart G. Monoclonal antibodies with thyroid stimulating activity at last. Thyroid. 2002;12(12):1039\u201341. https:\/\/doi.org\/10.1089\/105072502321085126.","journal-title":"Thyroid"},{"issue":"3","key":"309_CR34","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1365-2265.2010.03831.x","volume":"73","author":"M Evans","year":"2010","unstructured":"Evans M, Sanders J, Tagami T, Sanders P, Young S, Roberts E, et al. Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample. Clin Endocrinol (Oxf). 2010;73(3):404\u201312. https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03831.x.","journal-title":"Clin Endocrinol (Oxford)"},{"key":"309_CR35","first-page":"81","volume":"46","author":"P Sanders","year":"2011","unstructured":"Sanders P, Young S, Sanders J, Kabelis K, Baker S, Sullivan A, et al. Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody. J Mol Endocrinol. 2011;46:81\u201399.","journal-title":"J Mol Endocrinol"},{"issue":"11","key":"309_CR36","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1089\/thy.2006.16.1077","volume":"16","author":"N Nakatake","year":"2006","unstructured":"Nakatake N, Sanders J, Richards T, Burne P, Barrett C, Pra CD, et al. Estimation of serum TSH receptor autoantibody concentration and affinity. Thyroid. 2006;16(11):1077\u201384. https:\/\/doi.org\/10.1089\/thy.2006.16.1077.","journal-title":"Thyroid"},{"key":"309_CR37","doi-asserted-by":"publisher","first-page":"182176","DOI":"10.1155\/2012\/182176","volume":"2012","author":"N Takasu","year":"2012","unstructured":"Takasu N, Matsushita M. Changes of TSH-stimulation blocking antibody (TSBAb) and thyroid stimulating antibody (TSAb) over 10 years in 34 TSBAb-positive patients with hypothyroidism and in 98 TSAb-positive Graves\u2019 patients with hyperthyroidism: reevaluation of TSBAb and TSAb in TSH-receptor-antibody (TRAb)-positive patients. J Thyroid Res. 2012;2012:182176. https:\/\/doi.org\/10.1155\/2012\/182176.","journal-title":"J Thyroid Res"},{"issue":"2","key":"309_CR38","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/cen.13908","volume":"90","author":"P Nalla","year":"2019","unstructured":"Nalla P, Young S, Sanders J, Carter J, Adlan MA, Kabelis K, et al. Thyrotrophin receptor antibody concentration and activity, several years after treatment for Graves\u2019 disease. Clin Endocrinol (Oxf). 2019;90(2):369\u201374. https:\/\/doi.org\/10.1111\/cen.13908.","journal-title":"Clin Endocrinol (Oxford)"},{"issue":"7","key":"309_CR39","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1089\/thy.2007.0327","volume":"18","author":"J Sanders","year":"2008","unstructured":"Sanders J, Evans M, Betterle C, Sanders P, Bhardwaja A, Young S, et al. A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity. Thyroid. 2008;18(7):735\u201346. https:\/\/doi.org\/10.1089\/thy.2007.0327.","journal-title":"Thyroid"},{"key":"309_CR40","doi-asserted-by":"publisher","unstructured":"N\u00fa\u00f1ez Miguel R, Sanders P, Allen L, Evans M, Holly M, Johnson W, et al. Structure of full-length TSH receptor in complex with antibody K1-70\u2122. J Mol Endocrinol. 2022;70(1):e220120. https:\/\/doi.org\/10.1530\/JME-22-0120","DOI":"10.1530\/JME-22-0120"},{"issue":"6","key":"309_CR41","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/cen.14681","volume":"96","author":"J Furmaniak","year":"2022","unstructured":"Furmaniak J, Sanders J, Sanders P, Li Y, Rees Smith B. TSH receptor specific monoclonal autoantibody K1-70 TM targeting of the TSH receptor in subjects with Graves\u2019 disease and Graves\u2019 orbitopathy\u2014results from a phase I clinical trial. Clin Endocrinol (Oxf). 2022;96(6):878\u201387. https:\/\/doi.org\/10.1111\/cen.14681.","journal-title":"Clin Endocrinol (Oxford)"},{"issue":"8","key":"309_CR42","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1507\/endocrj.EJ25-0043","volume":"72","author":"JY Noh","year":"2025","unstructured":"Noh JY, Watanabe N, Ito K, Tsuiki M, Ishihara Y, Tagami T, et al. Safety, pharmacokinetics, and potential benefits of TSH-receptor-specific monoclonal autoantibody K1-70TM in Japanese Graves\u2019 disease patients: results of a phase 1 trial. Endocr J. 2025;72(8):897\u2013909. https:\/\/doi.org\/10.1507\/endocrj.EJ25-0043.","journal-title":"Endocr J"},{"issue":"4","key":"309_CR43","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1111\/andr.70001","volume":"14","author":"WA Hendrickson","year":"2026","unstructured":"Hendrickson WA, Gong Z. Structural and evolutionary insights into the functioning of glycoprotein hormones and their receptors. Andrology. 2026;14(4):952\u201367. https:\/\/doi.org\/10.1111\/andr.70001.","journal-title":"Andrology"},{"issue":"3","key":"309_CR44","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jmb.2011.08.057","volume":"413","author":"JL Miller","year":"2011","unstructured":"Miller JL, Tate CG. Engineering an ultra-thermostable \u03b21-adrenoceptor. J Mol Biol. 2011;413(3):628\u201338. https:\/\/doi.org\/10.1016\/j.jmb.2011.08.057.","journal-title":"J Mol Biol"},{"issue":"3","key":"309_CR45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1530\/JME-18-0213","volume":"62","author":"J Miller-Gallacher","year":"2019","unstructured":"Miller-Gallacher J, Sanders P, Young S, Sullivan A, Baker S, Reddington S, et al. Crystal structure of a ligand-free stable TSH receptor leucine-rich repeat domain. J Mol Endocrinol. 2019;62(3):117\u201328. https:\/\/doi.org\/10.1530\/JME-18-0213.","journal-title":"J Mol Endocrinol"},{"issue":"2","key":"309_CR46","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1530\/JOE-20-0061","volume":"246","author":"HP Holthoff","year":"2020","unstructured":"Holthoff HP, Uhlan K, Kovacs GL, Reimann A, Adler K, Wenhart C, et al. Thyroid-stimulating hormone receptor (TSHR) fusion proteins in Graves\u2019 disease. J Endocrinol. 2020;246(2):135\u201347. https:\/\/doi.org\/10.1530\/JOE-20-0061.","journal-title":"J Endocrinol"},{"issue":"11","key":"309_CR47","doi-asserted-by":"publisher","first-page":"104178","DOI":"10.1016\/j.drudis.2024.104178","volume":"29","author":"D Pliatsika","year":"2024","unstructured":"Pliatsika D, Blatter C, Riedl R. Targeted protein degradation: current molecular targets, localization, and strategies. Drug Discov Today. 2024;29(11):104178. https:\/\/doi.org\/10.1016\/j.drudis.2024.104178.","journal-title":"Drug Discov Today"},{"issue":"Pt A","key":"309_CR48","doi-asserted-by":"publisher","first-page":"110873","DOI":"10.1016\/j.intimp.2023.110873","volume":"124","author":"H Duan","year":"2023","unstructured":"Duan H, Jiang Z, Chen L, Bai X, Cai H, Yang X, et al. TSHR-based chimeric antigen receptor T cell specifically deplete auto-reactive B lymphocytes for treatment of autoimmune thyroid disease. Int Immunopharmacol. 2023;124(Pt A):110873. https:\/\/doi.org\/10.1016\/j.intimp.2023.110873.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"309_CR49","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1210\/clinem\/dgab819","volume":"107","author":"H Li","year":"2022","unstructured":"Li H, Zhou X, Wang G, Hua D, Li S, Xu T, et al. CAR-T cells targeting TSHR demonstrate safety and potent preclinical activity against differentiated thyroid cancer. J Clin Endocrinol Metab. 2022;107(4):1110\u201326. https:\/\/doi.org\/10.1210\/clinem\/dgab819.","journal-title":"J Clin Endocrinol Metab"},{"key":"309_CR50","doi-asserted-by":"publisher","DOI":"10.5962\/bhl.title.8281","volume-title":"The clonal selection theory of acquired immunity","author":"M Burnet","year":"1959","unstructured":"Burnet M. The clonal selection theory of acquired immunity. Nashville: Vanderbilt Univ Press; 1959."},{"key":"309_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-011-8095-5","volume-title":"Auto-immunity and auto-immune disease: a survey for physician or biologist","author":"M Burnet","year":"1972","unstructured":"Burnet M. Auto-immunity and auto-immune disease: a survey for physician or biologist. Lancaster: Medical and Technical Publishing Co Ltd; 1972."},{"issue":"8117","key":"309_CR52","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-026-10493-9","volume":"654","author":"PA Nicola","year":"2026","unstructured":"Nicola PA, Lawson ARJ, Tidd A, Imbert J, Ishida Y, Wylie LA, et al. Polyclonal selection of immune checkpoint mutations in thyroid autoimmunity. Nature. 2026;654(8117):131\u201341. https:\/\/doi.org\/10.1038\/s41586-026-10493-9.","journal-title":"Nature"}],"container-title":["Thyroid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13044-026-00309-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-026-00309-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-026-00309-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:43:25Z","timestamp":1784630605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13044-026-00309-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["309"],"URL":"https:\/\/doi.org\/10.1186\/s13044-026-00309-3","relation":{},"ISSN":["1756-6614"],"issn-type":[{"value":"1756-6614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"I am a director and shareholder of the RSR group of companies which develop and manufacture diagnostics and therapeutics for autoimmune diseases.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"21"}}